YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer stock may be coming out of a pandemic slump, now that it's in pole position for a coronavirus vaccine.
This week, its stock jumped 8% and hit a 52-week high of nearly $42, before settling down some.
The question remains whether a vaccine development ultimately would have a significant impact on the pharmaceutical giant’s bottom line. A key factor is how many other companies are standing at the finish line with vaccines of their own.
Read more from Fortune.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach